 |
 printable version
HIV prevalence, HIV mortality, antiretroviral therapy needs and targets for the 49 "3 by 5" focus countries (June 2004):
Previous page |
1,2,3
HIV prevalence, HIV mortality, antiretroviral therapy needs and targets for the 49 "3 by 5" focus countries
Part 1
| High burden country |
WHO focus country |
Estimated number of people living with
HIV/AIDS
(0-49 years), end 2003a |
Estimated adult prevalence of HIV/AIDS (15–49 years),end
2003a |
Estimated annual deaths from AIDS (0–49 years),
2003a |
Estimated total number needing antiretroviral therapy in
2005b |
| ü |
Angola |
240
000 |
3.90% |
21
000 |
32
000 |
| |
Belize |
3
600 |
2.40% |
<200 |
440 |
| ü |
Botswana |
350
000 |
37.30% |
33
000 |
60
000 |
| ü |
Burkina Faso |
300
000 |
4.20% |
29
000 |
43
000 |
| ü |
Burundi |
250
000 |
6.00% |
25
000 |
38
000 |
| ü |
Cambodiac |
170
000 |
2.60% |
15
000 |
28
000 |
| ü |
Cameroon |
560
000 |
6.90% |
49
000 |
85
000 |
| ü |
Central African
Republic |
260
000 |
13.50% |
23
000 |
39
000 |
| ü |
China |
840
000 |
0.10% |
44
000 |
100
000 |
| |
Costa Rica |
12
000 |
0.60% |
900 |
2
500 |
| ü |
Côte d'Ivoire |
570
000 |
7.00% |
47
000 |
78
000 |
| ü |
Democratic Republic
of the Congo |
1
100 000 |
4.20% |
100
000 |
160
000 |
|
Djibouti |
9
100 |
2.90% |
770 |
1
200 |
| |
El Salvador |
29
000 |
0.70% |
2
200 |
4
700 |
| ü |
Ethiopia |
1 500 000 |
4.40% |
120
000 |
200
000 |
| ü |
Ghana |
350
000 |
3.10% |
30
000 |
52
000 |
| ü |
Guatemala |
78
000 |
1.10% |
5
800 |
12
000 |
| ü |
Guinea |
140
000 |
3.20% |
9
000 |
16
000 |
|
Guyana |
11
000 |
2.50% |
1
100 |
2
000 |
| ü |
Haiti |
280
000 |
5.60% |
24
000 |
40
000 |
|
Honduras |
63
000 |
1.80% |
4
100 |
7
400 |
| ü |
Indiad,e |
NA |
NA |
NA |
710
000 |
|
Indonesia |
110
000 |
0.10% |
2
400 |
7
100 |
| |
Kazakhstan |
16
500 |
0.20% |
<200 |
460 |
| ü |
Kenya |
1 200 000 |
6.70% |
150
000 |
220
000 |
| |
Kyrgyzstan |
3
900 |
0.10% |
<200 |
48 |
| ü |
Lesotho |
320
000 |
28.90% |
29
000 |
54
000 |
| ü |
Malawi |
900
000 |
14.20% |
84
000 |
130
000 |
| ü |
Mozambique |
1 300 000 |
12.20% |
110
000 |
190
000 |
| ü |
Myanmar |
330
000 |
1.20% |
20
000 |
42
000 |
| ü |
Namibia |
210
000 |
21.30% |
16
000 |
29
000 |
| |
Nicaragua |
6
400 |
0.20% |
<500 |
930 |
| ü |
Nigeria |
3 600 000 |
5.40% |
310
000 |
520
000 |
| |
Panama |
16
000 |
0.90% |
<500 |
2
200 |
| ü |
Russian Federationf |
860
000 |
1.10% |
NA |
71
000 |
| ü |
Rwanda |
250
000 |
5.10% |
22
000 |
36
000 |
|
Somalia |
NA |
NA |
NA |
NA |
| ü |
South Africa |
5
300 000 |
21.50% |
370
000 |
750
000 |
| ü |
Sudan |
400
000 |
2.30% |
23
000 |
43
000 |
| ü |
Swaziland |
220
000 |
38.80% |
17
000 |
32
000 |
|
Tajikistan |
<200 |
<0.1% |
NA |
NA |
| ü |
Uganda |
530
000 |
4.10% |
78
000 |
110
000 |
| ü |
Ukraineg |
360
000 |
1.40% |
20
000 |
45
000 |
| ü |
United Republic
of Tanzania |
1
600 000 |
8.80% |
160
000 |
260
000 |
|
Uzbekistan |
11
000 |
0.10% |
<500 |
770 |
| ü |
Viet Nam |
220
000 |
0.40% |
9
000 |
22
000 |
|
Yemen |
12
000 |
0.10% |
NA |
NA |
| ü |
Zambia |
920
000 |
16.50% |
89
000 |
140
000 |
| ü |
Zimbabwe |
1 800 000 |
24.60% |
170
000 |
290
000 |
| a
The WHO/UNAIDS Working Group on Surveillance and Estimates generates
estimates for number of people living with HIV/AIDS, adult
prevalence rate and annual deaths from AIDS using Spectrum software. |
| b
The estimated total number needing antiretroviral therapy is based on the
estimated two-year mortality plus 80% of those currently
receiving treatment. |
| c
Cambodia has estimated the number of people living with HIV/AIDS as 157500 and antiretroviral therapy need as 22000 based on calculations by the National Center for HIV/AIDS, Dermatology and STD (NCHADS). |
| d
For India, the current number of people on antiretroviral therapy need is
an average between an independent coverage survey and the
country profile data. |
| e
For India, the declared antiretroviral therapy target refers to the
country’s commitment to begin treatment in April 2004 but not to a
specific target date of the end of 2005. |
| f The
Russian Federation has estimated the need for antiretroviral therapy to be
139 000 based on calculations made by their Federal
AIDS Center. |
| g
Ukraine’s country-declared target is for March 2005. |
| h
Most of the difference between the 187 505 people receiving antiretroviral
therapy reported for the 49 focus countries and the global number of 440 000 in developing and transitional countries is Brazil, where 140000 people are receiving treatment. |
HIV prevalence, HIV mortality, antiretroviral therapy needs and targets for the 49 "3 by 5" focus countries (June 2004):
1,2,3
| Next page
|
